It is well established that early screening for polyps in family members of patients with characterized mutations in MMR (Lynch syndrome), APC (FAP), or MUTYH (MAP) genes is beneficial in improving detection of malignant changes and reduces mortality. The gene discussed is APC; the disease is Lynch syndrome.